Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

34 results
Display

Cerebral Venous Thrombosis Presenting in Pregnancy with Thrombocytosis and Janus Kinase 2 Valine-to-Phenylalanine Mutation

Yoon SJ, Woo MH, Chung D, Kim J

A 30-year-old woman in her first pregnancy was admitted with headache and horizontal diplopia indicating left abducens nerve palsy. Brain magnetic resonance imaging revealed a cerebral venous thrombosis. She had...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib

March-Rodriguez A, Bellosillo B, Álvarez-Larrán A, Besses C, Pujol RM, Toll A

Ruxolitinib is a Janus kinase (JAK)1 and JAK2 inhibitor approved for the treatment of myelofibrosis and for polycythemia patients who are resistant or intolerant to hydroxyurea. We report a 72...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Rare Case of Polycythemia Vera Following Acute Undifferentiated Leukemia Remission

Youk HJ, Cho CH, Lee JH, Choi CW, Lim CS, Yoon SY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ischemic Stroke with Extracranial Internal Carotid Artery Occlusion in Essential Thrombocythemia with JAK-2 Mutation

Lee JE, Jung AR, Choi JH, Kim TK, Kwon E, Lee CY, Chun MY, Chang Y, Kim YJ, Song TJ

In essential thrombocythemia (ET), cerebral infarction with large cerebral artery occlusion has rarely been reported. A 53-year-old male was admitted with left sided weakness. Brain magnetic resonance images revealed right...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Straightforward Identification of Masked Polycythemia Vera Based on Proposed Revision of World Health Organization Diagnostic Criteria for BCR-ABL1-Negative Myeloproliferative Neoplasms

Chu D, Cho YU, Jang S, Seo EJ, Park CJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A t(8;9)(p22;p24)/PCM1-JAK2 Translocation in a Patient With Myeloproliferative Neoplasm and Myeloid Sarcoma: First Report in Korea

Song I, Lee DH, Lee JH, Jang S, Huh JR, Seo EJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlations between Janus Kinase 2 V617F Allele Burdens and Clinicohematologic Parameters in Myeloproliferative Neoplasms

Ha JS, Kim YK, Jung SI, Jung HR, Chung IS

  • KMID: 2434478
  • Ann Lab Med.
  • 2012 Nov;32(6):385-391.
BACKGROUND: This study evaluated potential correlations between the allele burden of the Janus kinase 2 (JAK2) V617F mutation and clinicohematologic characteristics in patients with myeloproliferative neoplasms (MPN). METHODS: Clinical and hematologic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms

Ha JS, Kim YK

BACKGROUND: Calreticulin (CALR) mutations were recently discovered in patients with myeloproliferative neoplasms (MPNs). We studied the frequency and type of CALR mutations and their hematological characteristics. METHODS: A total of 168...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peroxisome Proliferator-activated Receptor-gamma Inhibits the Activation of STAT3 in Cerulein-stimulated Pancreatic Acinar Cells

Ju KD, Lim JW, Kim H

Cerulein-induced pancreatitis is similar to human edematous pancreatitis, characterized by the dysregulation of digestive enzyme production, edema formation, and an infiltration of inflammatory cells into the pancreas. We previously showed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm

Park SH, Chi HS, Cho YU, Jang S, Park CJ

BACKGROUND: We aimed to evaluate the feasibility of using the allele burden of Janus kinase 2 (JAK2) V617F as a criterion for discriminating 3 subtypes of Philadelphia chromosome-negative myeloproliferative neoplasm...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Atypical Chronic Myeloid Leukemia with the JAK2V617F Mutation

Kim JY, Lee SR, Nam MH, Yoon SY, Lim CS, Lee CK, Kim BS, Cho Y, Kim YK, Lee KN

Atypical chronic myeloid leukemia (aCML) is a rare leukemic disorder that shows myelodysplastic and myeloproliferative features simultaneously. The Janus kinase 2 gene V617F mutation (JAK2V617F) in aCML has been the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Myeloproliferative Neoplasm with a Concurrent JAK2V617F Mutation and BCR/ABL Translocation without Chronic Myelogenous Leukemia Phenotype Acquisition during Hydroxyurea Treatment

Park SH, Chi HS, Cho YU, Jang S, Park CJ, Kim DY, Lee JH, Lee KH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Janus Kinase 2 Inhibitor AG490 Inhibits the STAT3 Signaling Pathway by Suppressing Protein Translation of gp130

Seo IA, Lee HK, Shin YK, Lee SH, Seo SY, Park JW, Park HT

The binding of interleukin-6 (IL-6) cytokine family ligands to the gp130 receptor complex activates the Janus kinase (JAK)/ signal transducer and activator of transcription 3 (STAT3) signal transduction pathway,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections

Abdolmaleki M, Sohrabi A

BACKGROUND: Human papillomavirus (HPV) genotypes that infect the genital tract play a main etiologic role in cervical cancer progression. Other environmental factors, such as sexually transmitted diseases and the host...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Angiotensin II on Gene Expression of cGMP-Specific Phosphodiesterases

Kim D, Hong BK, Kwon HM, Kim DY, Cho YH, Yoon SJ, Kim HS, Yan C

BACKGROUND AND OBJECTIVES: Angiotensin II (Ang II) opposes the actions of nitric oxide (NO). A balance between Ang II and NO is critical for the maintenance of normal vessel tone,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of IGFBP-3 on Adipokines and Gene Expression in Differentiated 3T3-L1 Adipocytes

Kim HS

PURPOSE: IGFBP-3 leads to the induction of insulin resistance in 3T3-L1 adipocytes. We carried out a series of experiments to elucidate the effects of IGFBP-3 on adipokines and gene expressions. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling

Kim BH, Yi EH, Li YC, Park IC, Park JY, Ye SK

PURPOSE: The chemical structure of tubulosine has been known since the mid-1960s. However, little is known about its biological and pharmacological functions. The aim of this study was to investigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Procaine Attenuates Pain Behaviors of Neuropathic Pain Model Rats Possibly via Inhibiting JAK2/STAT3

Li D, Yan Y, Yu L, Duan Y

Neuropathic pain (NPP) is the main culprit among chronic pains affecting the normal life of patients. Procaine is a frequently-used local anesthesia with multiple efficacies in various diseases. However, its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic Usefulness of the Janus Kinase 2 Mutation in non BCR/ABL Myeloproliferative Disorders

Bang SM, Ahn JY, Park J, Yoo SJ, Park SH, Nam EM, Park PW, Seo YH, Cho EK, Shin DB, Lee JH

BACKGROUND: We investigated the Janus kinase 2 (JAK2) mutation and its diagnostic value in patients suffering with non BCR/ABL myeloproliferative diseases (nMPD) or other reactive conditions. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of STAT3 Phosphorylation in Ethanol-Mediated Proliferation of Breast Cancer Cells

Narayanan , Nandabalan SK, Baddireddi LS

PURPOSE: In this study, we investigated the molecular mechanism involved in ethanol (EtOH)-mediated proliferation of breast cancer cells. METHODS: EtOH concentration was optimized by studying its effect on cell proliferation in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr